Clinical implications of universal germline testing in breast cancer patients in an Arab population: The Jordanian Exploratory Cancer Genetics (Jo-ECAG) study

被引:0
|
作者
Abdel-Razeq, Hikmat
Nielsen, Sarah M.
Sharaf, Baha'
Hani, Hira Bani
Russell, Emily M.
Heald, Brandie
Alkyam, Mais
Abujamous, Lama
Mustafa, Rawan Mohammed Mahmoud
Al-Azzam, Khansa
Elemian, Shatha
Abu-Fares, Hala
Allah, Majd Hamed
Zeidan, Zeidan
Nussbaum, Robert Luke
Esplin, Edward D.
机构
[1] King Hussein Canc Ctr, Amman, Jordan
[2] Invitae, San Francisco, CA USA
[3] King Hussien Canc Ctr, Amman, Jordan
[4] Invitae, San Leandro, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e22535
引用
收藏
页数:1
相关论文
共 50 条
  • [31] The clinical implications of staging laparoscopy in the diagnostic workup of gastric cancer patients: A population based study
    van der Sluis, K.
    Vollebergh, M. A.
    Kodach, L. L.
    van Dieren, J. M.
    de Hingh, I. H. J. T.
    Wijnhoven, B. P. L.
    Verhoeven, R. H. A.
    van Sandick, J. W.
    EJSO, 2024, 50 (10):
  • [32] CLINICAL CHARACTERISTICS ASSOCIATED WITH HIGH-RISK CANCER-PREDISPOSITION GERMLINE MUTATIONS IN PATIENTS WITH UROTHELIAL CARCINOMA: IMPLICATIONS FOR GENETIC TESTING
    Hong Truong
    Clements, Matthew
    Sheikh, Rania
    Lenis, Andrew
    Reisz, Peter
    Escano, Manuel
    Kemel, Yelena
    Benfante, Nicole
    Khurram, Aliya
    Vijai, Joseph
    Goh, Alvin
    Cha, Eugene
    Donahue, Timothy
    Iyer, Gopa
    Coleman, Jonathan
    Pietzak, Eugene
    Rosenberg, Jonathan
    Solit, David
    Offit, Kenneth
    Bajorin, Dean
    Bochner, Bernard
    Carlo, Maria
    JOURNAL OF UROLOGY, 2021, 206 : E733 - E733
  • [33] Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients Clinical Testing with a Multigene Test Panel
    Kwong, Ava
    Shin, Vivian Y.
    Chen, Jiawei
    Cheuk, Isabella W. Y.
    Ho, Cecilia Y. S.
    Au, Chun H.
    Chan, Karen K. L.
    Ngan, Hextan Y. S.
    Chan, Tsun L.
    Ford, James M.
    Ma, Edmond S. K.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (04): : 544 - 554
  • [34] Comprehensive germline multigene panel testing changes clinical care for patients with breast cancer: Untapped clinical utility and PARP inhibitor trial eligibility.
    Beitsch, Peter D.
    Whitworth, Pat W.
    Hughes, Kevin S.
    Patel, Rakesh
    Baron, Paul
    Rosen, Barry
    Grady, Ian
    Holmes, Dennis
    Simmons, Rache M.
    Smith, Linda Ann
    Compagnoni, Gia
    Coomer, Cynara L.
    Brown, Eric Allen
    Barbosa, Karen
    Clark, Patricia
    Gold, Linsey P.
    Riley, Lee B.
    Esplin, Edward D.
    Yang, Shan
    Nussbaum, Robert L.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] Access to germline testing and prevalence of somatic mutations in patients with breast cancer from disadvantaged areas: A single-center study
    Alharbi, Malak
    Roy, Arya Mariam
    Krishnan, Jayasree
    Patel, Archit
    Patel, Riya Jayesh
    Kapoor, Ankita
    Attwood, Kristopher
    Catalfamo, Kayla
    Omilian, Angela
    Gage-Bouchard, Elizabeth R.
    Yao, Song
    O'Connor, Tracey L.
    Levine, Ellis Glenn
    Gandhi, Shipra
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab
    O'Malley, Frances P.
    Thomson, Tom
    Julian, Jim
    Have, Cherry
    Crosby, Roxanne
    Gelmon, Karen
    Andrulis, Irene
    Whelan, Tim
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2008, 132 (01) : 61 - 65
  • [37] Implications of somatic TP53 and PIK3CA mutations in patients with metastatic breast cancer who underwent germline BRCA testing
    Yam, Clinton
    Barrera, Angelica Gutierrez
    Huang, Davis
    Lin, Xinyi
    Litton, Jennifer K.
    Arun, Banu
    CANCER RESEARCH, 2018, 78 (04)
  • [38] Breast cancer and systemic sclerosis: a clinical description of 21 patients in a population-based cohort study
    Tim Y. -T. Lu
    Catherine L. Hill
    Eliza K. Pontifex
    Peter J. Roberts-Thomson
    Rheumatology International, 2008, 28 : 895 - 899
  • [39] Breast cancer and systemic sclerosis: a clinical description of 21 patients in a population-based cohort study
    Lu, Tim Y. -T.
    Hill, Catherine L.
    Pontifex, Eliza K.
    Roberts-Thomson, Peter J.
    RHEUMATOLOGY INTERNATIONAL, 2008, 28 (09) : 895 - 899
  • [40] Thai patients who fulfilled NCCN criteria for breast/ovarian cancer genetic assessment demonstrated high prevalence of germline mutations in cancer susceptibility genes: implication to Asian population testing
    Pongtawat Lertwilaiwittaya
    Ekkapong Roothumnong
    Panee Nakthong
    Peerawat Dungort
    Chutima Meesamarnpong
    Warisara Tansa-Nga
    Khontawan Pongsuktavorn
    Supakit Wiboonthanasarn
    Warunya Tititumjariya
    Wanna Thongnoppakhun
    Sirisak Chanprasert
    Chanin Limwongse
    Manop Pithukpakorn
    Breast Cancer Research and Treatment, 2021, 188 : 237 - 248